Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05016310 · ClinicalTrials.gov registry record · NA
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
A NA study of Breast Cancer and Osteoporosis, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT05016310: Completed NA study of Breast Cancer and Osteoporosis, sponsored by Wake Forest University Health Sciences.
NCT05016310 is a NA study of Breast Cancer and Osteoporosis that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 7 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05016310, a NA study of Breast Cancer and Osteoporosis, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized study evaluating the effects of early intensive vitamin D supplementation compared to standard of care vitamin D supplementation on bone health over an 18 month period.
Primary Outcome
Compare effect of high dose vitamin D to the current standard vitamin D treatment administration algorithm on bone health, as measured by percent change from baseline in bone mineral density (g/cm2) to the Year 1 planned DEXA scan, in young women with non-metastatic breast cancer who receive systemic therapy.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT High Dose Vitamin D
- DIETARY_SUPPLEMENT Standard of Care Vitamin D
Study Locations (1)
North Carolina
- Levine Cancer Institute - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-09-16 |
| Est. Completion | 2024-08-15 |
| Phase | NA |
What the finished NCT05016310 record still lists
NCT05016310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which High Dose Vitamin D is the first listed.
NCT05016310 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05016310 about?
NCT05016310 is a clinical study titled "A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation". This is a randomized study evaluating the effects of early intensive vitamin D supplementation compared to standard of care vitamin D supplementation on bone health over an 18 month period.
What is the current status of trial NCT05016310?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-09-16. Estimated completion is 2024-08-15.
What conditions does trial NCT05016310 study?
This clinical trial studies the following conditions: Breast Cancer, Osteoporosis, Breast.
What interventions are being tested in trial NCT05016310?
The interventions under investigation include: High Dose Vitamin D (DIETARY_SUPPLEMENT), Standard of Care Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05016310?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05016310 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05016310's enrollment target sits among peer trials
7 1202nd of 1224 higher than 17 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI